BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23977236)

  • 1. Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
    Yu Y; Chen Z; Wang H; Zhang Y
    PLoS One; 2013; 8(8):e72154. PubMed ID: 23977236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
    Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
    PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
    Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
    Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer.
    Stacey SN; Manolescu A; Sulem P; Thorlacius S; Gudjonsson SA; Jonsson GF; Jakobsdottir M; Bergthorsson JT; Gudmundsson J; Aben KK; Strobbe LJ; Swinkels DW; van Engelenburg KC; Henderson BE; Kolonel LN; Le Marchand L; Millastre E; Andres R; Saez B; Lambea J; Godino J; Polo E; Tres A; Picelli S; Rantala J; Margolin S; Jonsson T; Sigurdsson H; Jonsdottir T; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Sveinsdottir SG; Alexiusdottir K; Saemundsdottir J; Sigurdsson A; Kostic J; Gudmundsson L; Kristjansson K; Masson G; Fackenthal JD; Adebamowo C; Ogundiran T; Olopade OI; Haiman CA; Lindblom A; Mayordomo JI; Kiemeney LA; Gulcher JR; Rafnar T; Thorsteinsdottir U; Johannsson OT; Kong A; Stefansson K
    Nat Genet; 2008 Jun; 40(6):703-6. PubMed ID: 18438407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
    Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
    Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
    Milne RL; Goode EL; García-Closas M; Couch FJ; Severi G; Hein R; Fredericksen Z; Malats N; Zamora MP; Arias Pérez JI; Benítez J; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Cox A; Brock IW; Elliot G; Cross SS; Seal S; Turnbull C; Renwick A; Rahman N; Shen CY; Yu JC; Huang CS; Hou MF; Nordestgaard BG; Bojesen SE; Lanng C; Grenaker Alnæs G; Kristensen V; Børrensen-Dale AL; Hopper JL; Dite GS; Apicella C; Southey MC; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Chang-Claude J; Wang-Gohrke S; Radice P; Peterlongo P; Manoukian S; Barile M; Giles GG; Baglietto L; John EM; Miron A; Chanock SJ; Lissowska J; Sherman ME; Figueroa JD; Bogdanova NV; Antonenkova NN; Zalutsky IV; Rogov YI; Fasching PA; Bayer CM; Ekici AB; Beckmann MW; Brenner H; Müller H; Arndt V; Stegmaier C; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Meindl A; Heil J; Bartram CR; Schmutzler RK; Thomas GD; Hoover RN; Fletcher O; Gibson LJ; dos Santos Silva I; Peto J; Nickels S; Flesch-Janys D; Anton-Culver H; Ziogas A; Sawyer E; Tomlinson I; Kerin M; Miller N; Schmidt MK; Broeks A; Van 't Veer LJ; Tollenaar RA; Pharoah PD; Dunning AM; Pooley KA; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Jakubowska A; Lubinski J; Jaworska K; Durda K; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Kraft P; Lindstrom S; Chen X; Beesley J; Hamann U; Harth V; Justenhoven C; ; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Khusnutdinova E; Bermisheva M; Prokofieva D; Farahtdinova A; Olson JE; Wang X; Humphreys MK; Wang Q; Chenevix-Trench G; ; ; Easton DF
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2222-31. PubMed ID: 21795498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.
    Wu S; Cai J; Wang H; Zhang H; Yang W
    PLoS One; 2013; 8(8):e72526. PubMed ID: 23977314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants at 5p12 and risk of breast cancer in Han Chinese.
    Liu X; Qin Z; Shen H; Xue J; Jiang Y; Hu Z; Shen H; Wang S
    J Hum Genet; 2012 Oct; 57(10):638-41. PubMed ID: 22832384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
    Chen Q; Shi R; Liu W; Jiang D
    PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk.
    Yang Z; Shen J; Cao Z; Wang B
    Breast Cancer Res Treat; 2013 May; 139(1):267-75. PubMed ID: 23609471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
    Wang H; Yang Z; Zhang H
    Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.
    Wu X; Xu QQ; Guo L; Yu CT; Xiong YY; Wei ZY; Huo R; Li ST; Shen L; Niu JM; Liu L; Lin Y; He L; Qin SY
    PLoS One; 2013; 8(6):e65206. PubMed ID: 23785413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk.
    Hu B; Huang Y; Yu RH; Mao HJ; Guan C; Zhao J
    Tumour Biol; 2014 Mar; 35(3):2777-85. PubMed ID: 24254305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
    Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
    PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Genomic Analysis Predicts Causative
    Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
    Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
    Jia C; Cai Y; Ma Y; Fu D
    Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.
    Tu L; Yan B; Peng Z
    Mol Genet Genomics; 2015 Jun; 290(3):901-12. PubMed ID: 25475391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk variants associated with in situ breast cancer.
    Campa D; Barrdahl M; Gaudet MM; Black A; Chanock SJ; Diver WR; Gapstur SM; Haiman C; Hankinson S; Hazra A; Henderson B; Hoover RN; Hunter DJ; Joshi AD; Kraft P; Le Marchand L; Lindström S; Willett W; Travis RC; Amiano P; Siddiq A; Trichopoulos D; Sund M; Tjønneland A; Weiderpass E; Peeters PH; Panico S; Dossus L; Ziegler RG; Canzian F; Kaaks R
    Breast Cancer Res; 2015 Jun; 17(1):82. PubMed ID: 26070784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetic breast cancer susceptibility variants as prognostic factors.
    Fasching PA; Pharoah PD; Cox A; Nevanlinna H; Bojesen SE; Karn T; Broeks A; van Leeuwen FE; van't Veer LJ; Udo R; Dunning AM; Greco D; Aittomäki K; Blomqvist C; Shah M; Nordestgaard BG; Flyger H; Hopper JL; Southey MC; Apicella C; Garcia-Closas M; Sherman M; Lissowska J; Seynaeve C; Huijts PE; Tollenaar RA; Ziogas A; Ekici AB; Rauh C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Andrulis IL; Ozcelik H; Mulligan AM; Glendon G; Hall P; Czene K; Liu J; Chang-Claude J; Wang-Gohrke S; Eilber U; Nickels S; Dörk T; Schiekel M; Bremer M; Park-Simon TW; Giles GG; Severi G; Baglietto L; Hooning MJ; Martens JW; Jager A; Kriege M; Lindblom A; Margolin S; Couch FJ; Stevens KN; Olson JE; Kosel M; Cross SS; Balasubramanian SP; Reed MW; Miron A; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Chenevix-Trench G; ; Lambrechts D; Dieudonne AS; Hatse S; van Limbergen E; Benitez J; Milne RL; Zamora MP; Pérez JI; Bonanni B; Peissel B; Loris B; Peterlongo P; Rajaraman P; Schonfeld SJ; Anton-Culver H; Devilee P; Beckmann MW; Slamon DJ; Phillips KA; Figueroa JD; Humphreys MK; Easton DF; Schmidt MK
    Hum Mol Genet; 2012 Sep; 21(17):3926-39. PubMed ID: 22532573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.